Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors

[1]  M. Dubocovich,et al.  The enantiomers of the dopamine agonist N-0437: in vivo and in vitro effects on the release of striatal dopamine. , 1989, European journal of pharmacology.

[2]  N. Weiner,et al.  K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes. , 1989, The Journal of pharmacology and experimental therapeutics.

[3]  K. Inanaga,et al.  Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine , 1988, Biological Psychiatry.

[4]  P. Kalivas,et al.  Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. , 1988, The Journal of pharmacology and experimental therapeutics.

[5]  P. Duffy,et al.  Behavioral and neurochemical effects of acute and daily cocaine administration in rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[6]  P. Kalivas,et al.  Effects of Daily Cocaine and Morphine Treatment on Somatodendritic and Terminal Field Dopamine Release , 1988, Journal of neurochemistry.

[7]  M. Dubocovich,et al.  The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors. , 1988, European journal of pharmacology.

[8]  N. Mercuri,et al.  Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. , 1987, The Journal of physiology.

[9]  N. Zahniser,et al.  One injection of cocaine produces a long-lasting increase in [3H]-dopamine release , 1987, Pharmacology Biochemistry and Behavior.

[10]  N. Weiner,et al.  Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists. , 1987, The Journal of pharmacology and experimental therapeutics.

[11]  T. Robinson,et al.  Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.

[12]  N. Uretsky,et al.  Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine , 1985, Neuropharmacology.

[13]  H. Davis,et al.  Prevention of denervation atrophy in muscle: Mammalian neurotrophic factor is not transferrin , 1984, Brain Research.

[14]  F. J. White,et al.  Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronicd-amphetamine treatment , 1984, Brain Research.

[15]  G. Rebec,et al.  Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area. , 1984, Life sciences.

[16]  C. Schuster,et al.  A comparison of the subjective and cardiovascular effects of cocaine and lidocaine in humans , 1983, Pharmacology Biochemistry and Behavior.

[17]  T. Robinson,et al.  Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. , 1982, European journal of pharmacology.

[18]  Antelman Sm,et al.  Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis. , 1981 .

[19]  P. Seeman,et al.  Presynaptic subsensitivity as a possible basis for sensitization by long-term dopamine mimetics. , 1979, European journal of pharmacology.

[20]  M. Raiteri,et al.  Do presynaptic auto-receptors control dopamine release? , 1978, Nature.

[21]  S. Iversen,et al.  Selective 60HDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats , 1976 .

[22]  R. Post,et al.  Increasing effects of repetitive cocaine administration in the rat , 1976, Nature.

[23]  G. Cohen,et al.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. , 1975, Biochemical pharmacology.

[24]  P. Simon.  Psychopharmacological profile of cocaine , 1974 .

[25]  L. Dwoskin,et al.  Repeated cocaine administration results in supersensitivity of striatal D-2 dopamine autoreceptors to pergolide. , 1988, Life sciences.

[26]  B. Scatton.  Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity. , 1982, The Journal of pharmacology and experimental therapeutics.

[27]  W. Catterall.  Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. , 1980, Annual review of pharmacology and toxicology.

[28]  S. Snyder,et al.  Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. , 1973, The American journal of psychiatry.